Prosecution Insights
Last updated: April 19, 2026

Incyte Corporation

16 pending office actions

Portfolio Summary

16
Total Pending OAs
5
Final Rejections
11
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
18973200 RUXOLITINIB FOR THE TREATMENT OF PRURIGO NODULARIS WELLS, LAUREN QUINLAN 1622 Non-Final OA Dec 09, 2024
18625703 NOVEL PD-1 BINDING DOMAINS GAO, ASHLEY HARTMAN 1678 Final Rejection Apr 03, 2024
18381943 Tricyclic Urea Compounds As JAK2 V617F Inhibitors ISMAIL, REHANA 1625 Final Rejection Oct 19, 2023
18373648 ANTI-PD-1/LAG-3 BISPECIFIC ANTIBODIES AND USES THEREOF REDDIG, PETER J 1646 Non-Final OA Sep 27, 2023
18232970 TRICYCLIC TRIAZOLO COMPOUNDS AS DGK INHIBITORS REDWOOD, CHRISTOPHER EVAN 1629 Non-Final OA Aug 11, 2023
18330141 COMBINATION THERAPY OF ANTI-PD-1 ACTIVE AGENT, ANTI-TIM-3 ACTIVE AGENT, AND ANTI-LAG-3 ACTIVE AGENT FOR TREATING CANCER ALSOMAIRY, SARAH ABDOALATIF 1646 Non-Final OA Jun 06, 2023
18179838 SOLID FORMS, SALTS, AND PROCESSES OF PREPARATION OF A CDK2 INHIBITOR TOWNSLEY, SARA ELIZABETH 1629 Non-Final OA Mar 07, 2023
18176294 TOPICAL TREATMENT OF VITILIGO BY A JAK INHIBITOR GOTFREDSON, GAREN 1619 Final Rejection Feb 28, 2023
18162955 COMBINATION OF AN ANTI-CD19 ANTIBODY AND A BRUTON'S TYROSINE KINASE INHIBITOR AND USES THEREOF NATARAJAN, MEERA 1643 Final Rejection Feb 01, 2023
18092610 PD-L1/STING CONJUGATES AND METHODS OF USE JARRELL, NOBLE E 1699 Non-Final OA Jan 03, 2023
18089651 TOPICAL FORMULATION FOR A JAK INHIBITOR SOROUSH, LAYLA 1622 Non-Final OA Dec 28, 2022
18085814 SALTS AND SOLID FORMS OF AN FGFR INHIBITOR AND PROCESSES OF PREPARING THEREOF ELENISTE, PIERRE PAUL 1622 Non-Final OA Dec 21, 2022
18062924 ANTI-MUTANT CALRETICULIN (CALR) ANTIBODIES AND USES THEREOF MARVICH, MARIA 1634 Non-Final OA Dec 07, 2022
17991482 COMBINATION THERAPY COMPRISING AN FGFR INHIBITOR AND A KRAS INHIBITOR VALLE, ERNESTO 1623 Final Rejection Nov 21, 2022
18056907 MULTISPECIFIC BINDING MOIETIES COMPRISING PD-1 AND TGF-BRII BINDING DOMAINS CUNNINGCHEN, KATHLEEN MARY 1646 Non-Final OA Nov 18, 2022
16791561 CYCLIN-DEPENDENT KINASE 2 BIOMARKERS AND USES THEREOF KATAKAM, SUDHAKAR 1658 Non-Final OA Feb 14, 2020

Managing Incyte Corporation's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month